John Kozarich

John W.
Kozarich is currently Chief Executive Officer & Director at Nucorion Pharmaceuticals, Inc., Chairman at Ligand Pharmaceuticals, Inc. since 2003, Adjunct Professor at The Scripps Research Institute, Trustee at Gordon Research Conferences, and Adjunct Professor at The University of Texas at Austin.
Former positions include Chief Executive Officer & Director at QLT, Inc. in 2013, Chief Executive Officer & Director at Curza Global LLC from 2019 to 2024, Chairman, President & Chief Science Officer at ActivX Biosciences, Inc. from 2014 to 2017, Chairman at Intec Pharma Ltd. from 2016 to 2021, Director at Poxel SA, Director at Adaptive Therapeutics, Inc., Independent Non-Executive Director at Corium LLC (Massachusetts) from 2007 to 2015, Independent Director at Travere Therapeutics, Inc. from 2015 to 2020, Director at Novelion Therapeutics, Inc., Vice President-Research & Development at Alkermes, Inc., Professor at the University of Maryland, Professor at Yale School of Medicine, and Vice President at Merck Research Laboratories Massachusetts LLC from 1992 to 2001.
Education includes a doctorate from Massachusetts Institute of Technology and an undergraduate degree from Boston College.